You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T cells gamma delta

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Taichung (HLA-G-CAR.BiTE allogeneic ?d T cells)

Not yet recruiting
  • Solid Tumor
  • HLA-G-CAR.BiTE allogeneic γδ T cells
  • Taichung, Non-US, Taiwan
    China Medical University Hospital
Nov 27, 2023

Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in

Not yet recruiting
  • Neuroblastoma
  • +2 more
  • Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Oct 6, 2022

Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified

Not yet recruiting
  • Glioblastoma
  • Autologous genetically modified gamma-delta T cells
  • Allogeneic genetically modified gamma-delta T cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Allogeneic Gamma Delta (?d) CAR T Cells

Enrolling by invitation
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • Stanford, California
  • +4 more
Jun 7, 2022

Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,

Recruiting
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • +2 more
  • Stanford, California
  • +6 more
Oct 19, 2022

Kidney Transplantation, CMV Infection Trial in Bordeaux (Cytotect)

Recruiting
  • Kidney Transplantation
  • CMV Infection
  • Bordeaux, France
    Hopital Pellegrin
Nov 18, 2021

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Brain Tumor Adult Trial in Birmingham (DRI cell therapy)

Recruiting
  • Brain Tumor Adult
  • DRI cell therapy
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 1, 2022

NSCLC Trial (KB-GDT-01)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • KB-GDT-01
  • (no location specified)
Sep 29, 2023

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • EAGD T-cell infusion (Phase I)
  • EAGD T-cell infusion (Expansion)
  • Westwood, Kansas
    University of Kansas Cancer Center
Mar 15, 2022

B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

Recruiting
  • B-cell Lymphoma
  • +5 more
  • Louisville, Kentucky
    Norton Cancer Institute
Jan 24, 2023

COVID - 19 Trial in Newcastle (TCB008)

Active, not recruiting
  • COVID - 19
  • Newcastle, United Kingdom
    Royal Victoria Infirmary
Mar 8, 2022

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Colorectal Cancer, Triple Negative Breast Cancer, Sarcoma Trial in Johor Bahru (Adoptive Cell Transfer of NKG2DL-targetting

Unknown status
  • Colorectal Cancer
  • +5 more
  • Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell
  • Johor Bahru, Johor, Malaysia
    Landmark Medical Centre
Sep 26, 2019

Gamma Delta T Cells in AML

Unknown status
  • Acute Myeloid Leukemia
  • Blood collection and bone marrow aspirate
  • Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jun 28, 2019

Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

Withdrawn
  • Advanced Hepatocellular Carcinoma
  • GDKM-100 injection
  • Zhuhai, Guangdong, China
    Zhuhai People'S Hospital
Jan 16, 2023

Acute Myeloid Leukemia Trial in Praha (OmnImmune®)

Completed
  • Acute Myeloid Leukemia
  • OmnImmune®
  • Praha, Czechia
    UHKT (Ustav hematologie a krevni transfuze)
Mar 29, 2021

Activated PI3Kdelta Syndrome (APDS); PASLI Disease Trial in Worldwide (CDZ173)

Active, not recruiting
  • Activated PI3Kdelta Syndrome (APDS); PASLI Disease
  • Bethesda, Maryland
  • +7 more
Jul 22, 2022

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Natural Killer T Cells ExpressingInvariant T Receptor :

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Physiopathology
  • Blood sample
  • Tours, France
    University Hospital
May 12, 2023

AML/MDS Trial in Copenhagen (iDLI)

Recruiting
  • AML/MDS
  • iDLI
  • Copenhagen, Denmark
    Copenhagen University Hospital, Rigshospitalet
Jan 13, 2023

COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)

Recruiting
  • COVID-19 Pandemic
  • +3 more
  • mRNA-1273.214 Vaccine
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Oct 26, 2022

Hematologic Malignancies Trial in Assiut (CD56)

Recruiting
  • Hematologic Malignancies
  • CD56
  • Assiut, Egypt
  • +1 more
Jul 20, 2022

COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)

Recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901a
  • Halifax, Nova Scotia, Canada
  • +6 more
Nov 16, 2022

Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer Trial in Worldwide (IV ICT01)

Recruiting
  • Solid Tumor, Adult
  • Hematopoietic/Lymphoid Cancer
  • IV ICT01
  • New Haven, Connecticut
  • +6 more
Oct 5, 2022